ISPOR - PT26 Health Economic Impact of Non-Persistence with Tamoxifen Adjuvant Endocrine Therapy in Pre-Menopausal Women with Early-Stage Breast Cancer: A Simulation Study

PT26 Health Economic Impact of Non-Persistence with Tamoxifen Adjuvant Endocrine Therapy in Pre-Menopausal Women with Early-Stage Breast Cancer: A Simulation Study

Abstract

Authors

S Fariman Elston Lafata J

Full Text Cite This Article

Back to Volume 27, Supplemental Issue 6S

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now